Clinical Trial Update: Phenytoin for Memory Impairment Secondary to Megestrol [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating phenytoin for memory impairment associated with megestrol acetate has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Phenytoin (Phenytoin)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Cognitive Impairment | Phase 4 | Status: COMPLETED | Results posted: 2019-09-09